Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies

被引：0
|
作者：
Macaluso, F. S. [1 ]
Ventimiglia, M. [2 ]
Orlando, A. [1 ]
机构：
[1] Villa Sofia Cervello Hosp, IBD Unit, Palermo, Italy
[2] Italian Minist Hlth, Directorate Gen Med Device & Pharmaceut Serv, Rome, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P727
引用
收藏
页码：857 / 858
页数：2
相关论文
共 50 条
  • [1] Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
    Macaluso, Fabio Salvatore
    Ventimiglia, Marco
    Orlando, Ambrogio
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1217 - 1227
  • [2] REAL WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, L.
    Mosli, M.
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, R.
    Khalid, Mona
    Loftus, Edward V.
    INTERNIST, 2018, 59 : S55 - S56
  • [3] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    GASTROENTEROLOGY, 2018, 154 (01) : S82 - S82
  • [4] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S57 - S58
  • [5] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Stefan Schreiber
    Axel Dignass
    Laurent Peyrin-Biroulet
    Greg Hather
    Dirk Demuth
    Mahmoud Mosli
    Rebecca Curtis
    Javaria Mona Khalid
    Edward Vincent Loftus
    Journal of Gastroenterology, 2018, 53 : 1048 - 1064
  • [6] Effectiveness and safety of vedolizumab in older versus younger adults with inflammatory bowel disease: A systematic review and meta-analysis
    Baker, J.
    Mountifield, R.
    Thynne, T.
    Zinellu, A.
    Barnes, A.
    Shanahan, E.
    Mangoni, A. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 118 - 118
  • [7] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Mosli, Mahmoud
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward Vincent, Jr.
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
  • [8] Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies
    Zheng, Dian-yu
    Wang, Yi-nuo
    Huang, Yu-Hong
    Jiang, Min
    Dai, Cong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 126
  • [9] REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB OVER ONE YEAR IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria M.
    Loftus, Edward V.
    GASTROENTEROLOGY, 2017, 152 (05) : S338 - S338
  • [10] Real world effectiveness of vedolizumab over one year in inflammatory bowel disease: a meta-analysis
    Schreiber, S.
    Dignass, A.
    Peyrin-Biroulet, L.
    Hather, G.
    Demuth, D.
    Khalid, J. M.
    Loftus, E. V.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S315 - S315
12345